First Allied Advisory Services’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-1,293
| Closed | -$207K | – | 1235 |
|
|
2020
Q2 | $207K | Buy |
+1,293
| New | +$207K | 0.01% | 993 |
|
|
2019
Q2 | – | Sell |
-2,754
| Closed | -$328K | – | 1238 |
|
|
2019
Q1 | $328K | Buy |
2,754
+384
| +16% | +$45.7K | 0.01% | 827 |
|
|
2018
Q4 | $258K | Hold |
2,370
| – | – | 0.01% | 842 |
|
|
2018
Q3 | $382K | Buy |
2,370
+306
| +15% | +$49.3K | 0.01% | 813 |
|
|
2018
Q2 | $272K | Sell |
2,064
-5,000
| -71% | -$659K | 0.01% | 920 |
|
|
2018
Q1 | $524K | Sell |
7,064
-1,977
| -22% | -$147K | 0.02% | 650 |
|
|
2017
Q4 | $503K | Hold |
9,041
| – | – | 0.02% | 653 |
|
|
2017
Q3 | $410K | Buy |
9,041
+15
| +0.2% | +$680 | 0.02% | 686 |
|
|
2017
Q2 | $304K | Sell |
9,026
-600
| -6% | -$20.2K | 0.01% | 820 |
|
|
2017
Q1 | $285K | Buy |
9,626
+600
| +7% | +$17.8K | 0.01% | 808 |
|
|
2016
Q4 | $248K | Buy |
9,026
+26
| +0.3% | +$714 | 0.01% | 883 |
|
|
2016
Q3 | $553K | Sell |
9,000
-3,800
| -30% | -$233K | 0.03% | 535 |
|
|
2016
Q2 | $245K | Buy |
12,800
+800
| +7% | +$15.3K | 0.01% | 838 |
|
|
2016
Q1 | $234K | Sell |
12,000
-100
| -0.8% | -$1.95K | 0.01% | 841 |
|
|
2015
Q4 | $467K | Buy |
12,100
+100
| +0.8% | +$3.86K | 0.02% | 602 |
|
|
2015
Q3 | $385K | Sell |
12,000
-1,000
| -8% | -$32.1K | 0.02% | 647 |
|
|
2015
Q2 | $396K | Sell |
13,000
-6,600
| -34% | -$201K | 0.02% | 707 |
|
|
2015
Q1 | $260K | Hold |
19,600
| – | – | 0.02% | 847 |
|
|
2014
Q4 | $284K | Buy |
19,600
+6,000
| +44% | +$86.9K | 0.02% | 786 |
|
|
2014
Q3 | $287K | Sell |
13,600
-74
| -0.5% | -$1.56K | 0.02% | 746 |
|
|
2014
Q2 | $407K | Sell |
13,674
-34
| -0.2% | -$1.01K | 0.03% | 600 |
|
|
2014
Q1 | $330K | Buy |
13,708
+54
| +0.4% | +$1.3K | 0.02% | 683 |
|
|
2013
Q4 | $278K | Buy |
13,654
+4,600
| +51% | +$93.7K | 0.02% | 693 |
|
|
2013
Q3 | $428K | Sell |
9,054
-4,000
| -31% | -$189K | 0.02% | 600 |
|
|
2013
Q2 | $497K | Buy |
+13,054
| New | +$497K | 0.04% | 484 |
|